Skip to main content
Premium Trial:

Request an Annual Quote

3rd Millennium Appoints Nathan Goodman Senior VP

NEW YORK, Oct 24 - 3rd Millennium, a bioinformatics consulting firm in Cambridge, Mass., said Tuesday it had appointed Nathan Goodman as senior vice president.

Goodman will assist 3rd Millennium’s president, Richard Dweck, in managing the firm’s core consulting business. He will also serve as program manager for the $1.8 million grant 3rd Millennium recently received from the Advanced Technology Program of the National Institute of Science and Technology in the US Department of Commerce for the study of biological pathways.

Until recently Goodman, a pioneer in the field of bioinformatics, worked for Compaq Computer, where he established a technical marketing group focused on bioinformatics applications in the pharmaceutical industry.

Prior to that he ran a research group at the Jackson Laboratory in Bar Harbor, Maine, working on information systems for large scale biological laboratories. He also ran the informatics core at the Whitehead Institute / MIT Center for Genome Research. At the Whitehead Institute   he developed laboratory information management systems for the center’s genomics research projects.  

Goodman has more than 25 years experience in the computer industry. He is co-author of the textbook “Concurrency Control and Recovery in Database Systems” and a columnist for Genome Technology , GenomeWeb’s sister publication.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.